Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Fresh Tracks Therapeutics Inc > Hope Mgmt is taking full advantage of the NCIB
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(134)
•••
Comment by Eoj123on Dec 06, 2022 6:47pm
92 Views
Post# 35154797

RE:RE:RE:RE:Hope Mgmt is taking full advantage of the NCIB

RE:RE:RE:RE:Hope Mgmt is taking full advantage of the NCIBYour talking out your azz

CashFlowADay wrote:

Trusting management is foolish. 

THEY ARE THE TOP LOSER IN 2022 AND PEOPLE STILL TRUST THEM.

They are also paying down debt this Quarter and not buying shares. 

Horribly run company with major shareholders in over their head.  Their opportunity cost of decisions made in the last year is MASSIVE and will likely continue to grow.



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities